SofWave Medical Ltd. (SOFWF)

Market Cap	409.79M +48.1%
Revenue (ttm)	104.35M +50.2%
Net Income	8.85M
EPS	0.22
Shares Out	n/a
PE Ratio	46.28
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	11.65
Previous Close	11.65
Day's Range	11.65 - 11.65
52-Week Range	7.00 - 16.49
Beta	0.65
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 5, 2026

About SofWave Medical

SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin firming and rejuvenation, tissue renewal, treatment of muscle, aging, and other physiological change in Israel, the United States, Europe, Southeast Asia, the Middle East, and internationally. The company offers an ultrasound technology that induces coagulation and subsequent revitalization for regenerated skin under the SUPERB brand; and non-invasive muscle toning technology under the Pure Impact VIP brand. It se...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2015
• Employees: 151
• Stock Exchange: OTCMKTS
• Ticker Symbol: SOFWF

Financial Performance

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Sep 3, 2026

Data Sources Report a data error